We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-2.2%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$53.7B
AUM Growth
-$2.95B
(-5.2%)
Cap. Flow
+$168M
Cap. Flow
% of AUM
0.31%
Top 10 Holdings %
Top 10 Hldgs %
35.03%
Holding
1,742
New
57
Increased
475
Reduced
481
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$234M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$120M |
| 3 |
Micron Technology
MU
|
+$114M |
| 4 |
CoStar Group
CSGP
|
+$112M |
| 5 |
Linde
LIN
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTAI Aviation
FTAI
|
+$421M |
| 2 |
AbbVie
ABBV
|
+$174M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$126M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$107M |
| 5 |
Capital One
COF
|
+$84.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.44% |
| 2 | Financials | 12.06% |
| 3 | Healthcare | 11.81% |
| 4 | Communication Services | 9.87% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
AstraZeneca
AZN
$255B
| $10.4M | 0.02% |
+53,761
| New | +$10.4M |
|
|
DFTX
402
Definium Therapeutics
DFTX
$5.68B
| $10.3M | 0.02% |
546,783
+284,783
| +109% | +$4.83M |
|
403
Jefferies Financial Group
JEF
$12.7B
| $10.3M | 0.02% |
248,846
-12,399
| -5% | -$644K |
|
|
SION
404
Sionna Therapeutics
SION
$2.13B
| $10.2M | 0.02% |
255,636
+175,774
| +220% | +$6.71M |
|
405
Ingredion
INGR
$6.46B
| $10.2M | 0.02% |
90,728
+3,466
| +4% | +$398K |
|
406
Kimberly-Clark
KMB
$36B
| $10.1M | 0.02% |
104,886
+1,288
| +1% | +$132K |
|
407
Public Storage
PSA
$55.4B
| $10.1M | 0.02% |
37,271
-8,008
| -18% | -$2.3M |
|
408
Truist Financial
TFC
$62.3B
| $10.1M | 0.02% |
219,056
+38,094
| +21% | +$1.88M |
|
409
Otis Worldwide
OTIS
$28.2B
| $9.93M | 0.02% |
128,773
+28,651
| +29% | +$2.51M |
|
410
EQT Corp
EQT
$31.1B
| $9.91M | 0.02% |
155,728
-4,856
| -3% | -$285K |
|
411
PayPal
PYPL
$49.3B
| $9.9M | 0.02% |
218,962
+43,228
| +25% | +$2.09M |
|
412
Denali Therapeutics
DNLI
$3.78B
| $9.9M | 0.02% |
515,721
| – | – |
|
413
Evergy
EVRG
$19.6B
| $9.83M | 0.02% |
119,939
+4,421
| +4% | +$349K |
|
|
P
414
Everpure Inc
P
$23.2B
| $9.69M | 0.02% |
164,054
+38,614
| +31% | +$2.62M |
|
415
eBay
EBAY
$50.7B
| $9.67M | 0.02% |
106,277
-68,342
| -39% | -$6.14M |
|
416
VeriSign
VRSN
$25.3B
| $9.63M | 0.02% |
38,771
-10,123
| -21% | -$2.41M |
|
|
XYZ
417
Block Inc
XYZ
$47.2B
| $9.6M | 0.02% |
159,542
+17,778
| +13% | +$1.08M |
|
418
Vir Biotechnology
VIR
$1.56B
| $9.59M | 0.02% |
1,070,812
+539,381
| +101% | +$4.3M |
|
419
Zebra Technologies
ZBRA
$12.6B
| $9.55M | 0.02% |
45,658
-2,192
| -5% | -$515K |
|
|
GRMN
420
Garmin
GRMN
$47.2B
| $9.52M | 0.02% |
41,052
-17,152
| -29% | -$3.84M |
|
421
Ameren
AEE
$30.6B
| $9.49M | 0.02% |
86,309
+14,298
| +20% | +$1.53M |
|
422
Kymera Therapeutics
KYMR
$9.33B
| $9.48M | 0.02% |
113,842
+18,795
| +20% | +$1.49M |
|
|
MANE
423
Veradermics Inc
MANE
$4.43B
| $9.47M | 0.02% |
+150,000
| New | +$7.57M |
|
424
Construction Partners
ROAD
$5.79B
| $9.47M | 0.02% |
85,220
-13,156
| -13% | -$1.58M |
|
425
Eversource Energy
ES
$27.8B
| $9.42M | 0.02% |
135,976
+36,128
| +36% | +$2.55M |
|
Similar funds
SCP
Ensign Peak Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Ensign Peak Advisors held 1,742 positions worth $53.7B, down 5.2% from $56.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Ensign Peak Advisors's Q1 2026 filing shows 57 new, 475 increased, 481 reduced and 34 closed positions. Its largest new stake was Novo Nordisk: 400,384 shares worth $14.7M. The largest sale was FTAI Aviation, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.
- Ensign Peak Advisors's largest Q1 2026 buy was Novo Nordisk: 400,384 shares worth $14.7M.
- Ensign Peak Advisors added most to Boston Scientific in Q1 2026, an estimated $234M increase.
- Ensign Peak Advisors's biggest Q1 2026 reduction was FTAI Aviation, cutting an estimated $421M.
- Ensign Peak Advisors fully exited Exact Sciences in Q1 2026, selling an estimated $17M.
- Ensign Peak Advisors's ten largest holdings make up 35% of its $53.7B portfolio in Q1 2026.
- Ensign Peak Advisors opened 57 new positions and closed 34 in Q1 2026.
- Ensign Peak Advisors's portfolio value fell 5.2% quarter-over-quarter to $53.7B.
Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.